Stock listing

NASDAQ:RLYP Relypsa Inc Stock

Follow Relypsa Inc into a list and get an email when it puts out news.

Last close · NASDAQ:RLYP

$31.99 USD

Close on Aug 31, 2016 · No longer trades

Nov 15, 2013 to last close +165.0% · weekly closes, Nov 15, 2013 – Aug 31, 2016
Lowest – highest close
$11.76 – $46.05 USDSince Nov 15, 2013 · lowest Oct 22, 2015 · highest Mar 18, 2014

Delisted NASDAQ:RLYP no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:RLYP
Asset type
Stock
Exchange
NASDAQ
Currency
USD

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
David McGirr
Other companies: X4 Pharmaceuticals, Inc. (Director · Since at least Nov 15, 2017); Rhythm Pharmaceuticals, Inc. (Director · Since at least Oct 4, 2017); Insmed Incorporated (Director · Since at least Oct 30, 2013); Roka Bioscience Inc (Director · Jul 16, 2014 – Jun 28, 2017 · Past); Cubist Pharmaceuticals Inc (SVP & Chief Financial Officer · Mar 31, 2010 – Feb 15, 2013 · Past)
Director · Nov 14, 2013 – Sep 1, 2016 · Past
Thomas J. Schuetz
Other companies: Compass Therapeutics, Inc. (Chief Executive Officer, Compass Therapeutics · Since at least Jun 17, 2020); Audentes Therapeutics Inc (Director · Jul 19, 2016 – Jan 15, 2020 · Past)
Director · Nov 14, 2013 – Sep 1, 2016 · Past
Mary CorbettSenior VP, Human Resources · Jun 3, 2016 – Sep 1, 2016 · Past
Monte MontgomeryChief Accounting Officer · Aug 1, 2016 – Sep 1, 2016 · Past

Open People

Log in to ask 6ix AI your own questions about Relypsa Inc.